Safety profile of combined therapy inhibiting EFGR and VEGF pathways in patients with advanced non-small-cell lung cancer: A meta-analysis of 15 phase II/III randomized trials.
about
The efficacy and safety of platinum plus gemcitabine (PG) chemotherapy with or without molecular targeted agent (MTA) in first-line treatment of non-small cell lung cancer (NSCLC).Usefulness of dynamic contrast-enhanced magnetic resonance imaging for predicting treatment response to vinorelbine-cisplatin with or without recombinant human endostatin in bone metastasis of non-small cell lung cancer.Comparative effectiveness of combined therapy inhibiting EGFR and VEGF pathways in patients with advanced non-small-cell lung cancer: a meta-analysis of 16 phase II/III randomized trialsPhase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer.Exosomes from Plasmodium-infected hosts inhibit tumor angiogenesis in a murine Lewis lung cancer model.Tyrosine Kinase Inhibitors and Vascular Toxicity: Impetus for a Classification System?Exposure-Response Analysis of Necitumumab Efficacy in Squamous Non-Small Cell Lung Cancer Patients.Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer.
P2860
Q33437650-2AA60C7C-31D3-4496-A7D0-1F85186546FBQ37545124-D41CDC9C-618C-481E-8B22-E07BF564626FQ37701719-1D88FF9E-5F7F-416A-8388-6C1B901FC271Q38388371-85929336-9821-4E6A-8943-A87F5FB1E41FQ38709057-6E21BFDC-0CB6-4CF9-9139-F48D0DA6D944Q38813467-D1206957-DF9E-4A80-94E0-850FA110F3F0Q41526288-DFB3E48B-4C68-423E-B64F-B6387E5D8E3EQ44669628-C1987AA0-1DB4-4A50-82E2-BB5CED230DDC
P2860
Safety profile of combined therapy inhibiting EFGR and VEGF pathways in patients with advanced non-small-cell lung cancer: A meta-analysis of 15 phase II/III randomized trials.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Safety profile of combined the ...... hase II/III randomized trials.
@en
Safety profile of combined the ...... hase II/III randomized trials.
@nl
type
label
Safety profile of combined the ...... hase II/III randomized trials.
@en
Safety profile of combined the ...... hase II/III randomized trials.
@nl
prefLabel
Safety profile of combined the ...... hase II/III randomized trials.
@en
Safety profile of combined the ...... hase II/III randomized trials.
@nl
P2093
P2860
P356
P1476
Safety profile of combined the ...... hase II/III randomized trials.
@en
P2093
Jiale Huang
Li-Juan Ji
Mingxin Xu
Xiaolong Qi
Yanjie Zhu
Yiqian Liu
P2860
P304
P356
10.1002/IJC.29377
P577
2014-12-12T00:00:00Z